# ABVC BIOPHARMA, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/abvc-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:54:48.717746+00:00 | | Last reviewed | 2026-10-16T13:54:48.717746+00:00 | ## Identity - Legal name: ABVC BIOPHARMA, INC. - Display name: ABVC BIOPHARMA, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T18:21:34.150947+00:00 | | Completeness | 0.409 | | Record Quality | 0.818 | | Directors | 8 | | Committees | 7 | | Governance events | 3 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Shuling Jiang: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9 - Chiao-Ling Hsu: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5 - Eugene Jiang: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:6 - Hsin-Hui Miao: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7 - Norimi Sakamoto: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8 - Yen-Hsin Chou: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10 - Yoshinobu Odaira: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11 - Yu-Min (Francis) Chung: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:12 ## Committees - Audit (audit). Chair: Yen-Hsin Chou. Members: Yen-Hsin Chou (chair, current); Chiao-Ling Hsu (member, current); Hsin-Hui Miao (member, current). committee_id=alpha:committee:abvc-biopharma-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Yen-Hsin Chou (member, unknown). committee_id=alpha:committee:abvc-biopharma-inc:audit-chair - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Chiao-Ling Hsu (member, unknown); Hsin-Hui Miao (member, unknown). committee_id=alpha:committee:abvc-biopharma-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: Norimi Sakamoto. Members: Norimi Sakamoto (chair, current); Chiao-Ling Hsu (member, current); Hsin-Hui Miao (member, current). committee_id=alpha:committee:abvc-biopharma-inc:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Norimi Sakamoto (member, unknown). committee_id=alpha:committee:abvc-biopharma-inc:compensation-chair-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: Yoshinobu Odaira. Members: Yoshinobu Odaira (chair, current); Chiao-Ling Hsu (member, current); Hsin-Hui Miao (member, current); Norimi Sakamoto (member, current). committee_id=alpha:committee:abvc-biopharma-inc:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Yoshinobu Odaira (member, unknown). committee_id=alpha:committee:abvc-biopharma-inc:nominating-and-governance-chair ## Executive leadership - Eugene Jiang: Chairman of the Board and Chief Business Officer (CBO). Status: current. claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:13 - Leeds Chow: Chief Financial Officer (CFO) - Resigned March 5, 2025 [CFO]. Status: current. claim_id=alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Eugene Jiang executive of ABVC BIOPHARMA, INC., effective 2026-03-03. Effective: 2026-03-03. Detected: 2026-10-16T13:54:48.717746+00:00. event_id=alpha:event:transition:1c6078a18cv8qk - CFO_CHANGED: Leeds Chow executive of ABVC BIOPHARMA, INC., effective 2026-03-03. Effective: 2026-03-03. Detected: 2026-10-16T13:54:48.717746+00:00. event_id=alpha:event:transition:1ek4ugrntjg61 - DIRECTOR_APPOINTED: Shuling Jiang seat on ABVC BIOPHARMA, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:54:48.717746+00:00. event_id=alpha:event:transition:1dq9xdw1nlmf3q ## Scoped resources - `alpha://company/abvc-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record - `alpha://company/abvc-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=identity - `alpha://company/abvc-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/abvc-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=board - `alpha://company/abvc-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=committees - `alpha://company/abvc-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=leadership - `alpha://company/abvc-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=ownership - `alpha://company/abvc-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=financials - `alpha://company/abvc-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=capital-structure - `alpha://company/abvc-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=compensation - `alpha://company/abvc-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=governance - `alpha://company/abvc-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/abvc-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=audit - `alpha://company/abvc-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=legal - `alpha://company/abvc-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=risk - `alpha://company/abvc-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=cyber - `alpha://company/abvc-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=ai-governance - `alpha://company/abvc-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=agents - `alpha://company/abvc-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=ecosystem - `alpha://company/abvc-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=events - `alpha://company/abvc-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=relationships - `alpha://company/abvc-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=assessments - `alpha://company/abvc-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:yen-hsin-chou","name":"Yen-Hsin Chou"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:yoshinobu-odaira","name":"Yoshinobu Odaira"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao"},"source_id":"board_seats"}` - Claim alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto"},"source_id":"board_seats"}` ## Leadership - Chiao-Ling Hsu: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Eugene Jiang: Director. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Hsin-Hui Miao: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Norimi Sakamoto: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Shuling Jiang: Director. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Yen-Hsin Chou: Director, Audit · Chair. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Yoshinobu Odaira: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Yu-Min (Francis) Chung: Director. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b. - Eugene Jiang: Chairman of the Board and Chief Business Officer (CBO). Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:13. Valid from: 2026-03-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2b997655635dddc8de140b981aeb79303a9cf5a38072cce63d10ead6ebdeca0. - Leeds Chow: Chief Financial Officer (CFO) - Resigned March 5, 2025. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:14. Valid from: 2026-03-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1976cd88806a0e249c6a75461be53883ca84ce66ef80bc2b3aafbbb7d39c4a44. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Yen-Hsin Chou; Members Yen-Hsin Chou (Chair); Chiao-Ling Hsu; Hsin-Hui Miao. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Compensation: Chair Norimi Sakamoto; Members Norimi Sakamoto (Chair); Chiao-Ling Hsu; Hsin-Hui Miao. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Nominating and Governance: Chair Yoshinobu Odaira; Members Yoshinobu Odaira (Chair); Chiao-Ling Hsu; Hsin-Hui Miao; Norimi Sakamoto. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ABVC BIOPHARMA, INC.. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd49af4431c0f7033e11438f0e40d1824e9a046d55e9ed804ff89de217d09260. ## Entity Status - Public listing published. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd49af4431c0f7033e11438f0e40d1824e9a046d55e9ed804ff89de217d09260. ## Published Fact - US. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd49af4431c0f7033e11438f0e40d1824e9a046d55e9ed804ff89de217d09260. ## Committee Appointment - Yen-Hsin Chou: chair, Audit. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Chiao-Ling Hsu: member, Audit. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Hsin-Hui Miao: member, Audit. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Norimi Sakamoto: chair, Compensation. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Chiao-Ling Hsu: member, Compensation. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Hsin-Hui Miao: member, Compensation. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Yoshinobu Odaira: chair, Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Chiao-Ling Hsu: member, Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Hsin-Hui Miao: member, Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. - Norimi Sakamoto: member, Nominating and Governance. Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b. ## Security Listing - ABVC (NASDAQ). Claim: alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd49af4431c0f7033e11438f0e40d1824e9a046d55e9ed804ff89de217d09260. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:cd49af4431c0f7033e11438f0e40d1824e9a046d55e9ed804ff89de217d09260: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/abvc-biopharma-inc). - alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b: [ABVC BIOPHARMA, INC. DEF 14A 2026-03-05](https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm). - alpha:projection-evidence:document:d2b997655635dddc8de140b981aeb79303a9cf5a38072cce63d10ead6ebdeca0: [ABVC 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1173313/000121390026023063/ea0278313-10k_abvcbio.htm). - alpha:projection-evidence:document:1976cd88806a0e249c6a75461be53883ca84ce66ef80bc2b3aafbbb7d39c4a44: [ABVC 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1173313/000121390026023063/ea0278313-10k_abvcbio.htm). - alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b: [Audit](https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/abvc-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/abvc-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/abvc-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T18:21:33.923653+00:00; recorded 2026-10-16T18:21:33.923653+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.